MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%
Sector Heatmap
Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%
DGX — Quest Diagnostics Inc.
NYSEQuest Diagnostics Inc.
$231.09
-1.98(-0.85%)
- O
- 232.74
- H
- 233.33
- L
- 230.47
- V
- 990.28K
⏱️ End-of-day dataAs of Oct 1, 2026
Quest Diagnostics Inc. Statistics
Total Valuation
| Market Cap | $26.08B |
| Enterprise Value | $26.09B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | 2026-10-06 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | 110.37M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | 103.17 |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3,301.29 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 159,045.32 |
| P/OCF Ratio | 98,800.88 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 98,821.09 |
| EV / Sales | n/a |
| EV / EBITDA | 47,348.04 |
| EV / EBIT | 65,385.38 |
| EV / FCF | 159,077.86 |
Financial Position
| Current Ratio | 1.18 |
| Quick Ratio | n/a |
| Debt / Equity | 0.74 |
| Debt / EBITDA | 10.40 |
| Debt / FCF | 34.93 |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | 3.41% |
| Return on Assets (ROA) | 1.58% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $5 |
| Employee Count | 57,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | $74.00K |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | +26.92% |
| 50-Day Moving Average | $237.68 |
| 200-Day Moving Average | $205.83 |
| Relative Strength Index (RSI) | 45.18 |
| Average Volume (20 Days) | 1,136,219 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | $942.00K |
| Operating Income | $404.00K |
| Pretax Income | $334.00K |
| Net Income | $264.00K |
| EBITDA | $551.00K |
| EBIT | $399.00K |
| Earnings Per Share | $2.24 |
Balance Sheet
| Cash & Cash Equivalents | $393.00K |
| Total Debt | $5.73M |
| Net Cash | -$5.34M |
| Net Cash Per Share | $-0.05 |
| Equity (Book Value) | $7.75M |
| Book Value Per Share | $0.07 |
| Working Capital | $389.00K |
Cash Flow
| Operating Cash Flow | $264.00K |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | $164.00K |
| FCF Per Share | $0.00 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
| Dividend Per Share | $3.44 |
| Dividend Yield | 1.49% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 0.97% |
| FCF Yield | 0.00% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
| Lynch Fair Value | $33.60 |
| Lynch Upside | -85.46% |
| Graham Number | $1.88 |
| Graham Upside | -99.19% |
Stock Splits
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |